Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

One and Half Million Hematopoietic Stem Cell Transplants (HSCT). Dissemination, Trends and Potential to Improve Activity By Telemedicine from the Worldwide Network for Blood and Marrow Transplantation (WBMT)

Blood (2019) 134 (Supplement_1): 2035.

https://doi.org/10.1182/blood-2019-125232

Published: 2019

Journal Articles

Narrowing the Gap for Hematopoietic Cell Transplantation in the East-Mediterranean/African Region: Comparison with Global HSCT Indications and Trends. A Report on Behalf of the East Mediterranean (EMBMT), African Blood and Marrow Transplantation Group (AFBMT) and Worldwide Network for Blood and Marrow Transplantation (WBMT)

Blood (2017) 130 (Supplement 1): 3389.

https://doi.org/10.1182/blood.V130.Suppl_1.3389.3389

Published: 2017

Journal Articles

Mature Results of a Phase 1-2 Open-Label, Dose-Escalation Study of Intravenous SNS01-T in Patients (pts) with Relapsed or Refractory B-Cell Malignancies

David S. Siegel, MD PhD, Andrew McDonald, MBChB, Nicolas Novitzky, MD PhD, William Bensinger, Michael Craig, MD, Frits van Rhee, MD PhD, Martin Gutierrez, MD, Edward N. Libby, MD, John Thompson, Alice S Bexon, MD, Charles Barranco, Catherine A Taylor, Richard Dondero, Leslie J. Browne, PhD, Michael R. Kurman, MD, John A. Lust, MD PhD

Blood (2014) 124 (21): 4464.

https://doi.org/10.1182/blood.V124.21.4464.4464

Published: 2014

Journal Articles

Allogeneic Stem Cell Transplantation with Immunodepleted Grafts for Lymphoproliferative Malignancies

Nicolas Novitzky, MD PhD, Valda Thomas, Dipl, MDech

Blood (2014) 124 (21): 1252.

https://doi.org/10.1182/blood.V124.21.1252.1252

Published: 2014

Journal Articles

Pharmacokinetic (PK) and Pharmacodynamic (PD) Results of a Novel, First-in-Class Modulator of Eukaryotic Translation Initiation Factor 5A (eIF5A) in Patients (pts) with Relapsed or Refractory B-Cell Malignancies: Data from a Phase 1-2 Study

Alice S Bexon, MD, Michael Craig, MD, David S. Siegel, MD PhD, William Bensinger, Nicolas Novitzky, MD PhD, Andrew McDonald, MBChB, Martin Gutierrez, MD, Edward N. Libby, MD, Frits van Rhee, MD PhD, Jeremy Heidel, PhD, John Thompson, Charles Barranco, Catherine A Taylor, Kathleen A. Donovan, PhD, Laurie L. Moon-Tasson, BA, Leslie J. Browne, PhD, Michael R. Kurman, MD, John A. Lust, MD PhD, Richard Dondero

Blood (2014) 124 (21): 2121.

https://doi.org/10.1182/blood.V124.21.2121.2121

Published: 2014

Journal Articles

Global Hematopoietic Stem Cell Transplantation (HSCT) At One Million: An Achievement Of Pioneers and Foreseeable Challenges For The Next Decade. A Report From The Worldwide Network For Blood and Marrow Transplantation (WBMT)

Blood (2013) 122 (21): 2133.

https://doi.org/10.1182/blood.V122.21.2133.2133

Published: 2013

Journal Articles

Global Trends in Hematopoietic Cell Transplantation.

Helen Baldomero, Mahmoud Aljurf, MD, Luis Fernando Bouzas, MD, MSC, Alois Gratwohl, MD, Yoshihisa Kodera, MD, PhD, Jeff H Lipton, MD, J. Alejandro Madrigal, MD, PhD, Lida Minako, Nicolas Novitzky, MD, PhD, Marcelo C Pasquini, MD, MS, Jakob R. Passweg, Adriana Seber, MD, Jeffrey Szer, MBBS, Dietger Niederwieser, MD

Blood (2012) 120 (21): 3143.

https://doi.org/10.1182/blood.V120.21.3143.3143

Published: 2012

Journal Articles

Function and Clonality of T-Cells In Myelodysplasia

Glenda Davison, BSc, Nicolas Novitzky, MD, PhD, Rygana Abdulla, Ntl, Dip, Med, Tech

Blood (2010) 116 (21): 4972.

https://doi.org/10.1182/blood.V116.21.4972.4972

Published: 2010

Journal Articles

Is There a Role for Autologous Stem Cell Transplantation (Auto SCT) for Patients with Acute Myelogenous Leukaemia? A Retrospective Analysis.

Nicolas Novitzky, MD, PhD, Valda Thomas, Dipl, MedTech, Cecile du Toit, MBChB, MMed, Andrew McDonald, MBChB, FCP(SA)

Blood (2010) 116 (21): 1689.

https://doi.org/10.1182/blood.V116.21.1689.1689

Published: 2010

Journal Articles

Plasmablastic Lymphoma – A Single Institution Experience.

Zainab Mohamed, MBChB, FFRad, Nicolas Novitzky, MD, PhD, Andrew McDonald, MBChB, FCP

Blood (2009) 114 (22): 5003.

https://doi.org/10.1182/blood.V114.22.5003.5003

Published: 2009

Journal Articles

A Review of HIV Related Burkitt's Lymphoma/Leukemia in Sub Saharan Africa.

Nicolas Novitzky, MD, PhD, Jaimendra Singh, MBChB, FCP

Blood (2009) 114 (22): 5016.

https://doi.org/10.1182/blood.V114.22.5016.5016

Published: 2009

Journal Articles

Increasing Anthracycline Dose during Induction Chemotherapy Leads to Higher Remission Rates in Acute Myelogenous Leukaemia (AML).

Nicolas Novitzky, MD, PhD, Cecile E. Du Toit, MBChB,MMed, Andrew B. McDonald, MBChB;FCP

Blood (2007) 110 (11): 4388.

https://doi.org/10.1182/blood.V110.11.4388.4388

Published: 2007

Journal Articles

In Patients with Aplastic Anaemia, Conditioning with Reduced Intensity Followed by Infusion of T-Cell Depleted Grafts Is Associated with Limited Transplant Related Morbidity and Universal Survival.

Nicolas Novitzky, MD, PhD, Valda Thomas, Dip Med Tech, Cecile E. Du Toit, MBChB, MMed, Andrew B. McDonald, MBChB, FCP

Blood (2007) 110 (11): 3289.

https://doi.org/10.1182/blood.V110.11.3289.3289

Published: 2007

Journal Articles

Myeloablative Conditioning Followed by T-Cell Depletion Is Associated with Low Treatment Related Mortality.

Nicolas Novitzky, MD, PhD, Valda Thomas, N.D., Med Tech, Cecile du Toit, MBChB, M.Med, Andrew McDonald, MBChB, FCP

Blood (2006) 108 (11): 5221.

https://doi.org/10.1182/blood.V108.11.5221.5221

Published: 2006

Journal Articles

In Multiple Myeloma (MM) CAMPATH-1 Antibodies “In the Bag” Reduce the Early Toxicity of Stem Cell Transplantation from Graft vs. Host Disease (GvHD) and Seem To Be Associated with Improved Long Term Outcome.

Nicolas Novitzky, MD, PhD, Valda Thomas, N.D., Med Tech, Cecile du Toit, MBChB,M.Med.

Blood (2006) 108 (11): 5360.

https://doi.org/10.1182/blood.V108.11.5360.5360

Published: 2006

Journal Articles

Allogeneic Stem Cell Transplantation for Lymphoid Malignancies.

Nicolas Novitzky, MD, PhD, Valda Thomas, Cecile Du Toit, Andrew McDonald

Blood (2005) 106 (11): 5418.

https://doi.org/10.1182/blood.V106.11.5418.5418

Published: 2005

Journal Articles

Myeloablative Conditioning Is Well Tolerated by Older Patients Receiving T-Cell Depleted Grafts.

Nicolas Novitzky, MD, PhD, Valda Thomas, Geoff Hale, Herman Waldmann

Blood (2005) 106 (11): 5266.

https://doi.org/10.1182/blood.V106.11.5266.5266

Published: 2005

Journal Articles

Long Term Outcome of Patients Undergoing Splenectomy for Immune Thrombocytopenic Purpura.

Nicolas Novitzky, MD, PhD, Yunus Seth, Rosalia Mothupi

Blood (2004) 104 (11): 3936.

https://doi.org/10.1182/blood.V104.11.3936.3936

Published: 2004

Journal Articles

In Patients with Retroviral Infection Thrombotic Thrombocytopenic Purpura Is Highly Responsive to Infusions of Plasma.

Nicolas Novitzky, MD, PhD, Jacqueline Thomson, Louisa Abrahams, Cecile du Toit, Andrew McDonald

Blood (2004) 104 (11): 3114.

https://doi.org/10.1182/blood.V104.11.3114.3114

Published: 2004

Journal Articles

Radiotherapy-Based Conditioning Is Effective Immunosuppression for Patients Undergoing Transplantation with T-Cell Depleted Stem Cell Grafts for Severe Aplasia.

Nicolas Novitzky, MD, PhD, Valda Thomas, Helen Stubbings, Geoff Hale, Herman Waldmann

Blood (2004) 104 (11): 1819.

https://doi.org/10.1182/blood.V104.11.1819.1819

Published: 2004

NARROW

One and Half Million Hematopoietic Stem Cell Transplants (HSCT). Dissemination, Trends and Potential to Improve Activity By Telemedicine from the Worldwide Network for Blood and Marrow Transplantation (WBMT)

Mature Results of a Phase 1-2 Open-Label, Dose-Escalation Study of Intravenous SNS01-T in Patients (pts) with Relapsed or Refractory B-Cell Malignancies

Allogeneic Stem Cell Transplantation with Immunodepleted Grafts for Lymphoproliferative Malignancies

Pharmacokinetic (PK) and Pharmacodynamic (PD) Results of a Novel, First-in-Class Modulator of Eukaryotic Translation Initiation Factor 5A (eIF5A) in Patients (pts) with Relapsed or Refractory B-Cell Malignancies: Data from a Phase 1-2 Study

Global Hematopoietic Stem Cell Transplantation (HSCT) At One Million: An Achievement Of Pioneers and Foreseeable Challenges For The Next Decade. A Report From The Worldwide Network For Blood and Marrow Transplantation (WBMT)

Global Trends in Hematopoietic Cell Transplantation.

Function and Clonality of T-Cells In Myelodysplasia

Is There a Role for Autologous Stem Cell Transplantation (Auto SCT) for Patients with Acute Myelogenous Leukaemia? A Retrospective Analysis.

Plasmablastic Lymphoma – A Single Institution Experience.

A Review of HIV Related Burkitt's Lymphoma/Leukemia in Sub Saharan Africa.

Increasing Anthracycline Dose during Induction Chemotherapy Leads to Higher Remission Rates in Acute Myelogenous Leukaemia (AML).

In Patients with Aplastic Anaemia, Conditioning with Reduced Intensity Followed by Infusion of T-Cell Depleted Grafts Is Associated with Limited Transplant Related Morbidity and Universal Survival.

Myeloablative Conditioning Followed by T-Cell Depletion Is Associated with Low Treatment Related Mortality.

In Multiple Myeloma (MM) CAMPATH-1 Antibodies “In the Bag” Reduce the Early Toxicity of Stem Cell Transplantation from Graft vs. Host Disease (GvHD) and Seem To Be Associated with Improved Long Term Outcome.

Allogeneic Stem Cell Transplantation for Lymphoid Malignancies.

Myeloablative Conditioning Is Well Tolerated by Older Patients Receiving T-Cell Depleted Grafts.

Long Term Outcome of Patients Undergoing Splenectomy for Immune Thrombocytopenic Purpura.

In Patients with Retroviral Infection Thrombotic Thrombocytopenic Purpura Is Highly Responsive to Infusions of Plasma.

Radiotherapy-Based Conditioning Is Effective Immunosuppression for Patients Undergoing Transplantation with T-Cell Depleted Stem Cell Grafts for Severe Aplasia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only